VIR - Vir Biotechnology Inc
IEX Last Trade
8.25
-0.050 -0.606%
Share volume: 552,855
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.30
-0.05
-0.60%
Fundamental analysis
15%
Profitability
18%
Dept financing
5%
Liquidity
75%
Performance
0%
Performance
5 Days
-5.82%
1 Month
-18.54%
3 Months
-20.50%
6 Months
-28.79%
1 Year
-35.97%
2 Year
-66.08%
Key data
Stock price
$8.25
DAY RANGE
$8.16 - N/A
52 WEEK RANGE
$7.61 - $13.09
52 WEEK CHANGE
-$0.34
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO:
Region: US
Website: vir.bio
Employees: 562
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: vir.bio
Employees: 562
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Recent news